# drugs

Unikinon chloroquine pills are seen in packaging at the Uni-pharma pharmaceutical company in a northern suburb of Athens, on June 5, 2020, where chloroquine pills are produced. - The company was able to activate an old license to manufacture this controversial drug, which in the 1990s was exported to Africa for the treatment of malaria. Despite the controversy, production and trials of chloroquine are carried on. The scientific community and public opinion are reeling from the withdrawal of the disputed study in the journal The Lancet on the use of chloroquine. But in Greece, where the manufacture of this drug resumed during the pandemic, the controversy is almost non-existent. (Photo by Louisa GOULIAMAKI / AFP)
Unikinon chloroquine pills are seen in p […]

Amid global controversy, Greece moves forward with chloroquine

Seemingly unaffected by the controversy in the global scientific community, Greece has resumed production of chloroquine to treat cases of coronavirus and is conducting clinical trials
A bottle of Hydroxychloroquine pills pictured on a counter at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020. Photo: George Frey / AFP
A bottle of Hydroxychloroquine pills pic […]

WHO resumes trials on controversial drug as Italy reopens

The WHO says it will resume coronavirus trials on the controversial drug hydroxychloroquine, while Italy led European nations reopening borders as the pandemic carved its way through Latin America
Medical staff at the IHU Mediterranee Infection Institute in Marseille, France, display packets of Nivaquine tablets, containing chloroquine, and Plaqueril, containing hydroxychloroquine, drugs that has shown signs of effectiveness against coronavirus, on February 26, 2020. Photo: Gerard Julien / AFP
Medical staff at the IHU Mediterranee In […]

Medicine shortage looms over coronavirus-hit Europe

While the world waits for a coronavirus vaccine, medicines used to deal with the symptoms of the disease are increasingly in critically short supply in Europe, the worst-hit continent